Patients initially received two cycles of neoadjuvant docetaxel ( @ mg/m ( @ ) intravenously every @ weeks ) plus trastuzumab ( @ mg/kg intravenously every @ weeks then @ mg/kg intravenously every @ weeks for the second course ) .